Infection and learn more immunity 1994,62(8):3080–3085.PubMed
25. Lecuit M: Understanding how Listeria monocytogenes targets and crosses host barriers. Clin Microbiol Infect 2005,11(6):430–436.NCT-501 in vivo PubMedCrossRef 26. De Gottardi A, Touri F, Maurer CA, Perez A, Maurhofer O, Ventre G, Bentzen CL, Niesor EJ, Dufour JF: The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig Dis Sci 2004,49(6):982–989.PubMedCrossRef 27. Frankenberg T, Rao A, Chen F, Haywood J, Shneider BL, Dawson PA: Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids. Am J Physiol Gastrointest Liver Physiol 2006,290(5):G912-G922.PubMedCrossRef 28. Kosters A, Karpen SJ: The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis 2010,30(2):186–194.PubMedCrossRef 29. Triantis V, Saeland E, Bijl N, Oude-Elferink RP, Jansen PL: Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated
down-regulation of cytochrome P450 7A1. Hepatology 2010,52(2):656–666.PubMedCrossRef 30. Wu X, Li Y: Therapeutic utilities of fibroblast growth factor 19. Expert Opin Ther Targets click here 2011,15(11):1307–1316.PubMedCrossRef 31. Tomlinson E, Fu L, John L, Hultgren B, Huang X, Renz M, Stephan JP, Tsai SP, Powell-Braxton L, French D, et al.: Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 2002,143(5):1741–1747.PubMedCrossRef 32. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, Williams PM,
Soriano R, Corpuz R, Moffat B, et al.: Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 2004,145(6):2594–2603.PubMedCrossRef 33. Bhatnagar S, Damron HA, Hillgartner FB: Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J Biol Chem 2009,284(15):10023–10033.PubMedCrossRef 34. Wu X, Ge H, Lemon B, Vonderfecht S, Weiszmann J, Hecht R, Gupte J, Hager T, Wang Z, Lindberg R, et al.: FGF19-induced hepatocyte before proliferation is mediated through FGFR4 activation. J Biol Chem 2010,285(8):5165–5170.PubMedCrossRef 35. Uriarte I, Fernandez-Barrena MG, Monte MJ, Latasa MU, Chang HC, Carotti S, Vespasiani-Gentilucci U, Morini S, Vicente E, Concepcion AR, et al.: Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut 2013,62(6):899–910.PubMedCrossRef 36. Diaz-Delfin J, Hondares E, Iglesias R, Giralt M, Caelles C, Villarroya F: TNF-alpha represses beta-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. Endocrinology 2012,153(9):4238–4245.PubMedCrossRef 37.